Inactive Instrument

Press Releases Global Blood Therapeutics, Inc.

Equities

GBT

US37890U1088

Press Releases

Unlock all the news: Be the first to know and act before the market!

Pfizer Completes $5.4 Billion Acquisition Of Sickle Cell Disease Drug Innovator	22-10-27	AQ
GLOBAL BLOOD THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Regi (form 8-K)	22-10-05	AQ
GLOBAL BLOOD THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	22-09-30	AQ
GLOBAL BLOOD THERAPEUTICS, INC. : Other Events (form 8-K)	22-09-23	AQ
GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022	22-09-15	AQ
GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Disease Therapeutics Conference	22-09-08	AQ
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT	22-08-31	BU
Global Blood Therapeutics : Statement of Changes in Beneficial Ownership - Form 4	22-08-19	PU
Pfizer spending spree filters to Biopharma	22-08-10	AQ
Shareholder Alert - The M&A Class Action Firm Announces the Investigation of Global Blood Therapeutics, Inc. - GBT	22-08-09	PR
Global Blood: Q2 Earnings Snapshot	22-08-09	AQ
Pfizer scoops up Global Blood Therapeutics in $5.4bn deal	22-08-09	AQ
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT	22-08-08	BU
Pfizer buying spree continues with $5.4B hematology deal	22-08-08	AQ
Global Blood (GBT) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Global Blood Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – GBT	22-08-08	BU
Global Blood Therapeutics : Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology - Form 8-K	22-08-08	PU
GLOBAL BLOOD THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-08-08	AQ
GLOBAL BLOOD THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	22-08-08	AQ
GBT Announces New Employment Inducement Grants	22-08-04	AQ
Global Blood Therapeutics : Statement of Changes in Beneficial Ownership - Form 4	22-08-03	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Global Blood Therapeutics, Inc.

Equities

GBT

US37890U1088

Press Releases

Filters